These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36182987)

  • 1. Short-term efficacy of decitabine-based therapy in JMML: a retrospective study from a single center in China.
    Cai Y; Zhang J; Yi M; Zhang W; Liu X; Zhang X; Wan Y; Chang L; Zhang L; Chen X; Guo Y; Zou Y; Chen Y; Li J; Zhang Y; Yang W; Zhu X
    Int J Hematol; 2023 Jan; 117(1):121-127. PubMed ID: 36182987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decitabine-based treatment strategy improved the outcome of HSCT in JMML: a retrospective cohort study.
    Peng Z; Gao J; Huang L; He Y; Tang H; Zong S; Pei Y; Pei F; Ge J; Liu X; Yue L; Zhou J; Li X; Yue D; Chen Y; Chen C; Wu X; Feng X; Li C
    Front Immunol; 2024; 15():1426640. PubMed ID: 39253078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of DNA-hypomethylating agent and hematopoietic stem cell transplantation in treatment of juvenile myelomonocytic leukemia: A case report.
    Ai Y; Lu X; Zhu T; Zhu Y; Liu H; Sun S
    Medicine (Baltimore); 2020 Dec; 99(50):e23606. PubMed ID: 33327329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approaches.
    Fabri O; Horakova J; Bodova I; Svec P; Laluhova Striezencova Z; Bubanska E; Cermak M; Galisova V; Skalicka K; Vaska A; Doczyova D; Panikova A; Sykora T; Adamcakova J; Kolenova A
    Neoplasma; 2019 Sep; 66(5):818-824. PubMed ID: 31129971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients.
    Tüfekçi Ö; Koçak Ü; Kaya Z; Yenicesu İ; Albayrak C; Albayrak D; Yılmaz Bengoa Ş; Patıroğlu T; Karakükçü M; Ünal E; Ünal İnce E; İleri T; Ertem M; Celkan T; Özdemir GN; Sarper N; Kaçar D; Yaralı N; Özbek NY; Küpesiz A; Karapınar T; Vergin C; Çalışkan Ü; Tokgöz H; Sezgin Evim M; Baytan B; Güneş AM; Yılmaz Karapınar D; Karaman S; Uygun V; Karasu G; Yeşilipek MA; Koç A; Erduran E; Atabay B; Öniz H; Ören H
    Turk J Haematol; 2018 Mar; 35(1):27-34. PubMed ID: 28179213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine.
    Wajid M A; Gupta AK; Das G; Sahoo D; Meena JP; Seth R
    Pediatr Hematol Oncol; 2020 Oct; 37(7):573-581. PubMed ID: 32459546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of juvenile myelomonocytic leukemia.
    Sakashita K; Matsuda K; Koike K
    Pediatr Int; 2016 Aug; 58(8):681-90. PubMed ID: 27322988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
    Niemeyer CM; Flotho C; Lipka DB; Starý J; Rössig C; Baruchel A; Klingebiel T; Micalizzi C; Michel G; Nysom K; Rives S; Schmugge Liner M; Zecca M; Schönung M; Baumann I; Nöllke P; Benettaib B; Biserna N; Poon J; Simcock M; Patturajan M; Menezes D; Gaudy A; van den Heuvel-Eibrink MM; Locatelli F
    Blood Adv; 2021 Jul; 5(14):2901-2908. PubMed ID: 34297046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.
    Yoshimi A; Kojima S; Hirano N
    Paediatr Drugs; 2010; 12(1):11-21. PubMed ID: 20034338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of juvenile myelomonocytic leukemia.
    Liao XY; Qiu KY; Fang JP; Wu RH; Guo SY; Huang K; Zhou DH
    Hematology; 2019 Dec; 24(1):577-582. PubMed ID: 31389303
    [No Abstract]   [Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia with intestinal Behçet's disease: A case report.
    Liu C; Fu C; Guo X; Rong L; Li J; Fang Y
    Int J Rheum Dis; 2024 Jan; 27(1):e14882. PubMed ID: 37771000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen disparities reduce relapse after hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: A single-center retrospective study from China.
    Lin YC; Luo CJ; Miao Y; Wang JM; Luo CY; Qin X; Cai JY; Li BS; Chen J
    Pediatr Transplant; 2021 Mar; 25(2):e13825. PubMed ID: 33131184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
    Flotho C; Sommer S; Lübbert M
    Semin Cancer Biol; 2018 Aug; 51():68-79. PubMed ID: 29129488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of Gene Mutation and Clinical Characteristics in 19 Children with Juvenile Myelomonocytic Leukemia].
    Weng KZ; Zheng YZ; Zhuang SQ; Chen HY; LE SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1811-1818. PubMed ID: 33283703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile myelomonocytic leukemia (JMML): recent advances in molecular pathogenesis and treatment].
    Sakashita K
    Rinsho Ketsueki; 2016 Feb; 57(2):137-46. PubMed ID: 26935631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Study on Treatment of Juvenile Myelomonocytic Leukemia with Haploidentical-Hematopoietic Stem Cell Transplantation].
    Ding L; Zhu H; Han DM; Wang ZD; Zheng XL; Dong L; Yan HM; Liu J; Zhu L; Xue M; Guo ZK; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1524-1527. PubMed ID: 29070137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?
    De Vos N; Hofmans M; Lammens T; De Wilde B; Van Roy N; De Moerloose B
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29930. PubMed ID: 36094370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
    Chang TY; Dvorak CC; Loh ML
    Blood; 2014 Oct; 124(16):2487-97. PubMed ID: 25163700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.
    Hecht A; Meyer J; Chehab FF; White KL; Magruder K; Dvorak CC; Loh ML; Stieglitz E
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27948. PubMed ID: 31347788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.